HAP Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-15,100
| Closed | -$1.59K | – | 853 |
|
|
2025
Q2 | $1.59K | Buy |
+15,100
| New | +$1.88M | ﹤0.01% | 707 |
|
|
2023
Q1 | – | Sell |
-33,700
| Closed | -$184K | – | 1208 |
|
|
2022
Q4 | $184K | Hold |
33,700
| – | – | 0.02% | 488 |
|
|
2022
Q3 | $449K | Sell |
33,700
-26,000
| -44% | -$5.52M | 0.03% | 386 |
|
|
2022
Q2 | $168K | Buy |
59,700
+2,600
| +5% | +$532K | 0.01% | 770 |
|
|
2022
Q1 | $218K | Buy |
57,100
+37,100
| +186% | +$8.07M | 0.01% | 813 |
|
|
2021
Q4 | $134K | Sell |
20,000
-21,100
| -51% | -$5.43M | ﹤0.01% | 1139 |
|
|
2021
Q3 | $233K | Sell |
41,100
-25,700
| -38% | -$8.42M | 0.01% | 972 |
|
|
2021
Q2 | $942K | Sell |
66,800
-12,200
| -15% | -$3.7M | 0.03% | 477 |
|
|
2021
Q1 | $689K | Buy |
79,000
+52,000
| +193% | +$14M | 0.04% | 400 |
|
|
2020
Q4 | $267K | Buy |
27,000
+6,300
| +30% | +$1.63M | 0.01% | 851 |
|
|
2020
Q3 | $196K | Sell |
20,700
-11,700
| -36% | -$3.26M | 0.01% | 644 |
|
|
2020
Q2 | $101K | Buy |
32,400
+14,800
| +84% | +$4.45M | 0.01% | 851 |
|
|
2020
Q1 | $288K | Sell |
17,600
-23,000
| -57% | -$6.98M | 0.02% | 459 |
|
|
2019
Q4 | $869K | Buy |
40,600
+14,600
| +56% | +$4.05M | 0.05% | 224 |
|
|
2019
Q3 | $202K | Buy |
+26,000
| New | +$6.05M | 0.02% | 499 |
|
|
2019
Q2 | – | Sell |
-10,400
| Closed | -$30K | – | 1124 |
|
|
2019
Q1 | $30K | Buy |
+10,400
| New | +$3.27M | ﹤0.01% | 752 |
|
|
2018
Q4 | – | Sell |
-9,000
| Closed | -$240K | – | 1132 |
|
|
2018
Q3 | $240K | Buy |
+9,000
| New | +$3.1M | 0.02% | 418 |
|
|
2017
Q2 | – | Sell |
-15,400
| Closed | -$45K | – | 946 |
|
|
2017
Q1 | $45K | Sell |
15,400
-155,300
| -91% | -$43.9M | ﹤0.01% | 698 |
|
|
2016
Q4 | $34K | Sell |
170,700
-7,500
| -4% | -$2.22M | ﹤0.01% | 702 |
|
|
2016
Q3 | $721K | Buy |
178,200
+159,400
| +848% | +$47.2M | 0.03% | 311 |
|
|
2016
Q2 | $78K | Buy |
18,800
+6,400
| +52% | +$1.69M | ﹤0.01% | 541 |
|
|
2016
Q1 | $42K | Sell |
12,400
-1,800
| -13% | -$475K | ﹤0.01% | 550 |
|
|
2015
Q4 | $149K | Sell |
14,200
-8,500
| -37% | -$2.44M | 0.01% | 516 |
|
|
2015
Q3 | $76K | Buy |
+22,700
| New | +$7.5M | ﹤0.01% | 651 |
|
|
2015
Q1 | – | Sell |
-58,700
| Closed | -$1.24M | – | 942 |
|
|
2014
Q4 | $1.24M | Buy |
58,700
+7,800
| +15% | +$2.52M | 0.05% | 275 |
|
|
2014
Q3 | $1.34M | Buy |
50,900
+900
| +2% | +$297K | 0.05% | 302 |
|
|
2014
Q2 | $863K | Hold |
50,000
| – | – | 0.03% | 349 |
|
|
2014
Q1 | $1.46M | Buy |
+50,000
| New | +$15.9M | 0.07% | 258 |
|
|
2013
Q3 | – | Sell |
-62,000
| Closed | -$1.49M | – | 728 |
|
|
2013
Q2 | $1.49M | Buy |
+62,000
| New | +$13.2M | 0.05% | 278 |
|
Other funds holding BIIB
HAP Trading's BIIB Position: Q1 2023 in Review
HAP Trading sold out of Biogen (BIIB) in Q1 2023, closing a stake of 27,549 shares — an estimated $7.62M sold.
HAP Trading first reported a position in BIIB in Q1 2014 and held it in 18 quarters. The position peaked at $30.2M in Q4 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.
- HAP Trading reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
- HAP Trading sold 27,549 Biogen shares in Q1 2023, an estimated $7.62M.
- HAP Trading first reported a position in Biogen in Q1 2014 and held it in 18 quarters.
- HAP Trading's Biogen position peaked at $30.2M in Q4 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.
Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.